United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
42385-979_5fd82a02-46ac-4312-a008-fa17e5cd3ffd
Product NDC
42385-979
Form
TABLET, FILM COATED
Composition / generic term
Gabapentin
Labeler
Laurus Labs Limited
Marketing category
ANDA
Marketing start / end (source format)
20240409
Source listing expiry
20271231

Source-listed ingredients

  • GABAPENTIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED in 1 BOTTLE (42385-979-01) · 42385-979-01
  • 500 TABLET, FILM COATED in 1 BOTTLE (42385-979-05) · 42385-979-05
  • 1000 TABLET, FILM COATED in 1 BOTTLE (42385-979-11) · 42385-979-11
  • 30 TABLET, FILM COATED in 1 BOTTLE (42385-979-30) · 42385-979-30
  • 10 BLISTER PACK in 1 CARTON (42385-979-72) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 42385-979-72
  • 90 TABLET, FILM COATED in 1 BOTTLE (42385-979-90) · 42385-979-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →